Scaffold Biotech
PrivateLast Round
Seed
Feb 1, 2024
Total Funding Raised
$750,000
Company Overview
Scaffold Biotech is a biotechnology company that develops next-generation subunit vaccines for animal health using protein engineering and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scaffold Biotech Comparables
Compare Scaffold Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genvax Technologies | 79% | |
| ArkVax | 74% | |
| Merck & Co., Inc. | 63% | |
Scaffold Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2024 |
Scaffold Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LAB+ Company Builder | Seed |
| Agencia Nacional de Investigación e Innovación | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2024
$750K round led by LAB+ Company Builder
Scaffold Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Scaffold Biotech's valuation, stock price, and market status.